---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-012412"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:17:09.229821+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BioCardia receives Nasdaq delisting notice for equity shortfall; has until May 25 to submit compliance plan

## Summary
- Stockholders' equity was $895,000 as of Dec. 31, 2025, well below the $2.5M minimum required by Nasdaq Listing Rule 5550(b)(1).
- Notice received April 10, 2026; company must submit a plan to regain compliance by May 25, 2026.
- If Nasdaq accepts the plan, it may grant up to 180 days from April 10 to evidence compliance.
- Common stock continues trading on Nasdaq Capital Market under symbol BCDA; no immediate effect on listing.
- Failure to regain compliance could lead to delisting; company intends to submit a plan and may request a hearing if plan is rejected.

## SEC filing metadata
- accession: 0001437749-26-012412
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774926012412/0001437749-26-012412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774926012412/bcda20260414_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-012412
- JSON: https://secwatch.observer/filing/0001437749-26-012412.json
- Plain text: https://secwatch.observer/filing/0001437749-26-012412.txt

## Source-grounded claims
- claim_id: 869307d19047a413cd2cef84ef871ad2284ea69a
  claim: BioCardia, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: April 10, 2026, BioCardia, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of $895,000 as of December 31, 2025, it is no longer in compliance with the minimum stockholders’ equity requirement of $2.5 million for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1). The Company has until May 25, 2026 to provide Nasdaq with a plan to regain compliance with the foregoing listing requirement. If the Company’s plan to regain compliance is acc
  evidence_url: https://www.sec.gov/Archives/edgar/data/925741/000143774926012412/0001437749-26-012412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.